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ABSTRACT
Mouse CD8α
+ dendritic cells (DC) in lymphoid organs and CD103 + CD11b -DC in nonlymphoid tissues share phenotypic and functional similarities, as well as a unique shared developmental dependence on the transcription factor Batf3. Human DC resembling mouse CD8α + DC in phenotype and function have been identified in human blood, spleen and tonsil.
However, it is not clear whether such cells are also present in human non-lymphoid organs and their equivalence to mouse CD8α + DC has recently been questioned. Furthermore, the identification of "CD8α + DC-like" cells across different tissues and species remains problematic because of the lack of a unique marker that can be used to unambiguously define lineage members. Here we show that mouse CD8α + DC and CD103 + CD11b -DC can be defined by shared high expression of DNGR-1 (CLEC9A). We further show that DNGR-1 uniquely marks a CD11b -human DC population present in both lymphoid and non-lymphoid tissues of humans and humanized mice. Finally, we demonstrate that knockdown of Batf3 selectively prevents the development of DNGR-1 + human DC in vitro. Thus, high expression of DNGR-1 specifically and universally identifies a unique DC subset in mouse and human.
Evolutionarily-conserved Batf3 dependence justifies classification of DNGR-1 hi DC as a distinct DC lineage.
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INTRODUCTION
Dendritic cells (DCs) comprise a heterogeneous group of leukocytes with functions in both innate and adaptive immunity. In mouse, rat and human, multiple sub-types of DC can be defined in lymphoid and non-lymphoid tissues and in blood on the basis of differential expression of selected markers, as well as quantitative differences in antigen processing ability and in production of specific cytokines following stimulation [1] [2] [3] [4] [5] [6] [7] [8] [9] . However, the relationship between different DC subsets in different tissues and the equivalence of DC subtypes across species has been difficult to establish and remains controversial. Furthermore, the increased refinement of flow cytometric approaches, allowing cross-correlation of an everexpanding number of surface markers, has led to a marked increase in the number of putative DC subsets that can be defined phenotypically. For that reason, recent efforts have been directed towards supplementing phenotypic characterization with ontogenetic criteria, as well as using comparative analysis of global gene expression patterns, to define related DC subtypes across tissues and species 6, 10 .
The use of ontogenetic relationships has been successful in formally establishing the relatedness of mouse CD8α + DC from lymphoid tissues and CD103 + CD11b -DC from nonlymphoid tissues. CD8α + DC were originally identified as a discrete population of DC that expressed low levels of CD11b and SIRPα, high levels of CD8α, CD24, DEC-205 and DNGR-1 (CLEC9A) and variable levels of CD207 (langerin) and CD103
11
. CD8α-expressing DC have not generally been found outside mouse lymphoid tissues. However, mouse nonlymphoid tissues include a population of CD11b -SIRPα -DC that expresses CD103, CD24
and CD207. These cells are additionally found in lymph nodes, where they are thought to have immigrated from non-lymphoid tissues via the afferent lymph 11 . The phenotypic resemblance, as well as strong dependence on Flt3L for their development, led to the proposition that CD8α + DC resident in lymphoid tissues and CD103 + CD11b -DC from nonlymphoid tissues and lymph nodes are in fact closely related 12 . Consistent with that notion, GCACTGAAGGAGCACGAGA. LV were produced as previously described 30 .
In vitro-differentiated DC. Human Lin -CB cells were differentiated into DCs using a twostep protocol, as described previously 26 , except that round bottom well plates were used 
DC isolation.
Mouse, and human DC, were isolated from lymphoid and non-lymphoid organs as previously described 12, 32 . In brief, the organs were first cut in small pieces and incubated with a mixture of collagenase (type II for the spleen and lymph nodes or type IV for kidney and lung (Worthington Biochemical)) and of DNase (Sigma-Aldrich). After red blood cell lysis (Sigma-Aldrich), total single cell suspensions were stained for analysis.
RNA isolation and quantitative RT-PCR. RNA isolation, cDNA preparation and
quantitative RT-PCR were as described previously 26 . Levels of mRNA for the specific gene being measured were divided by those for GAPDH (normalized expression).
Statistical analyses. All statistical analyses were performed using Prism 5 software (GraphPad Software, Inc.).
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RESULTS
Mouse
On the basis of the above results, DNGR-1 would appear to act as a marker for the CD8α + -like DC family across species and across tissues. This family is currently best defined in the mouse on the basis of Batf3-dependence but this has not been established in the human.
The ability to grow DNGR-1 + BDCA3 + DC from CB HSCs/HPCs in a two-step culture (cord blood-derived DCs; CBDCs)the putative mouse counterparts. First, we screened ten Batf3-silencing shRNA lentivirus (LV) vector constructs bearing a puromycin selection marker and found two that appeared to selectively impair the development of puromycin-resistant DNGR-1 + DC (data not shown).
We sub-cloned these two Batf3-silencing hairpins, as well as two scrambled sequence controls (CTRL), into another lentiviral vector, in which the puromycin resistance locus is replaced with a gene encoding GFP, which acts as a marker of LV-transduced cells and their progeny. We produced shRNA LVs, used them to infect CBDC differentiation cultures and 
Batf3 silencing is not sufficient to impair DNGR-1 + BDCA3 + DCs development in humanized mice
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To assess the Batf3-dependence of human DNGR-1 + BDCA3 + DC in vivo, we generated humanized mice with human HSCs/HPCs that had been transduced with the different shRNA LV. To assess the stability of transduction in vivo, we isolated bone marrow from these mice at 7-8 weeks after transplantation and used it as a source of progenitors for in vitro DC differentiation (pseudo-"bone marrow-derived DCs"; BMDCs). We found that this approach allowed generation of a large fraction of GFP + DC from all mice, indicating that Figure 7B and data not shown). To ensure that this was not due to in vivo selection of cells resistant to Batf3 knockdown, we sorted human DC from the spleens of these animals and confirmed that there was a significant reduction of Batf3 mRNA in the GFP + ( Figure 7C ) but not the GFP -(data not shown) fraction. Furthermore, we confirmed that the knockdown was functional by showing that the bone marrow of these mice still failed to generate GFP + DNGR-1 + BDCA3 + DC upon ex vivo culture (see Figure 6 ). We conclude that Batf3 knockdown prevents development of DNGR-1 + BDCA3 + in vitro but that this can be by-passed in our humanized mouse model. 36 . In addition, DC can also play a key role in innate immunity, acting as a potent source of cytokines such as IFN-α/β or IL-12 11, 30 . In recent years, the heterogeneity of the DC system has become increasingly apparent 2, 6, 37 . An attempt to make sense of DC heterogeneity and to map equivalent DC subsets across species has led to efforts to define the ontogeny and transcriptome of phenotypically-distinct DC types in the hope that they might help define related DC sub-types 5, 7, 8, 10 . This approach has led to the definition of a Batf3- Expression of DNGR-1 in mouse spleen has previously been shown to be restricted to CD8α + DC and pDC 31, 33 . The latter express lower levels of the receptor 31, 33 . Expression of CD8α in some situations remains to be determined. Independently of additional markers, our current data clearly identify DNGR-1 as a specific and universal identifier of the Batf3-dependent CD8α + DC family across mouse and human. The ability to use anti-DNGR-1 to identify these cells in situ thus opens the door to further characterizing these cells in different human tissues, both in normal and pathological conditions. Finally, the identification of a common marker and the ontogenetic verification of a common DC lineage in both mice and humans underscores the usefulness of mouse models of DC function and reinforces the notion that antigen targeting to DNGR-1, which has been so successful in mice 31, 33, 38, 47, 48 , may yet serve as a useful strategy for immune modulation in Man 49 . or Batf3 -/-mice (lower left panel) were analyzed as in Figure 1 for the expression of CD103 
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